An explainable hybrid framework for early detection of cardiovascular diseases using Categorical Boosting and Bees algorithm
Related Experiment Video
Updated: Jan 8, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Jayanta Sen1, Sweta Bhattacharya2
1School of Computer Science Engineering and Information Systems (SCORE), Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India. jayanta.sen@vit.ac.in.
Insights
A new hybrid machine learning (ML) model accurately detects cardiovascular disease (CVD) and provides interpretable results for targeted therapies. This advanced framework enhances early disease detection and treatment planning.
Area of Science:
- Cardiovascular health
- Machine learning applications
- Artificial intelligence in medicine
Background:
- Cardiovascular disease (CVD) is a leading global cause of mortality.
- Early CVD detection is crucial for effective patient management.
- Traditional machine learning (ML) models for disease prediction often lack transparency (are "black-box").
Purpose of the Study:
- To develop an interpretable ML framework for accurate CVD detection.
- To provide insights into factors influencing CVD occurrence for targeted therapies.
- To enhance clinical decision-making through transparent AI predictions.
Main Methods:
- Utilized the Framingham Cardiovascular Disease (CVD) dataset.
- Applied Random Oversampling (RO) for data balancing and Min-Max scaling for normalization.
- Developed a hybrid ML model combining Categorical Boosting (CatBoost) and BEEs algorithms.
- Implemented Explainable Artificial Intelligence (XAI) techniques (LIME, SHAP) for interpretability.
Main Results:
- The hybrid ML model achieved 98.04% accuracy, 97.09% precision, 98.96% recall, 98.02% F1-score, and 97.16% specificity.
- The model demonstrated superior performance compared to existing state-of-the-art algorithms.
- XAI techniques identified key attributes contributing to CVD occurrence.
Conclusions:
- The proposed hybrid ML model offers a highly accurate and interpretable solution for CVD detection.
- Explainable AI provides valuable insights for healthcare providers, facilitating timely and accurate treatment decisions.
- This framework has the potential to significantly improve cardiovascular disease management and patient outcomes.
Abstract:
Cardiovascular disease (CVD) remains one of the leading causes of death worldwide, claiming millions of lives each year. The early detection of CVD enables healthcare professionals to make informed decisions about the patient's health. Machine learning (ML)- based frameworks have been extremely popular in predicting diseases. However, results generated from traditional ML models are "black-box," lacking transparency and interpretability. The objective of the present study is to develop an ML framework that detects CVD with promising accuracy and, further, provide interpretability to the generated outcomes to ensure targeted therapies. The Framingham, Massachusetts CVD dataset, which is publicly available from the Kaggle Repository, is used in this study. As part of the data pre-processing, the Random Oversampling (RO) technique is applied to overcome the data imbalance problem, followed by Pearson Correlation analysis to understand the correlation between attributes. Then, the Min-Max scaling technique is used for data normalization. The pre-processed data is fed into a hybrid ML framework incorporating the Categorical Boosting (CatBoost) and BEEs algorithms to achieve optimized CVD prediction results. The proposed Hybrid model yielded 98.04% accuracy, a Precision of 97.09%, a Recall of 98.96%, an F1-score of 98.02%, and a Specificity of 97.16%, with a total execution time of 26.6580 s. The proposed model outperformed contemporary state-of-the-art algorithms, considering most evaluation metrics. Additionally, Explainable Artificial Intelligence (XAI) techniques, such as LIME and SHAP, are implemented to identify the contribution of the most significant attributes towards the occurrence of CVD, offering valuable insights into the detection of the disease and enabling healthcare providers to make accurate and timely treatment decisions.
More Related Videos
08:22Author Spotlight: Advancing the Study of Brain-Heart Interplay with a Comprehensive EEGLAB Plugin for Multimodal Signal Analysis
Published on: April 26, 2024
07:35Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Classification of Illness
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
Classification of Signals
A continuous-time signal holds a value at every instant in time, representing information seamlessly. In contrast, a discrete-time signal holds values only at specific moments, often denoted as x(n), where...
Classification of Systems-II